Growth • Johnson & Johnson

JNJ

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

1,6%

CAGR Revenue 5Y

Revenue Compound Annual Growth Rate in the last 5 years.

1,1%

CAGR Op. Income 5Y

Operating Income Compound Annual Growth Rate in the last 5 years.

-1,4%

CAGR Net Income 5Y

Net Income Compound Annual Growth Rate in the last 5 years.

0,6%

CAGR EPS 5Y

Earnings Per Share Compound Annual Growth Rate in the last 5 years.

6,6%

CAGR Normalized EPS 5Y

Normalized Earnings Per Share Compound Annual Growth Rate in the last 5 years.

0,7%

CAGR OCF 5Y

Cash Flow from Operating activities Compound Annual Growth Rate in the last 5 years.

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!

Unrestricted access
Unlimited data history
Analysis videos
Quarterly highlights
Customizable financials table
Ranking
Discussions

...and much more!